Skip to content
StockMarketAgent
Healthcare / Health Information ServicesUpdated 2026-05-10 22:07 UTC

NSE/IKS stock hub

NSE/IKS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

NSE/IKSis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
291.1B
National Stock Exchange of India
Market data

Live price

Current market quote for this ticker.

Current price
NSE/IKS
In the news

Latest news · NSE/IKS

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E34.6
P25 24.9P50 32.4P75 45.7
Trailing P/E43.5
P25 24.8P50 35.9P75 56.9
ROEn/a
P25 6.3P50 13.6P75 18.1
ROIC25.9
P25 4.1P50 10.3P75 17.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All NSE/IKS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
153
Groups with data
10
Currency
INR
Showing 153 of 153 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
India
Country code
IN
Employees
7,530
Enterprise value
INR 296.5B
Exchange
National Stock Exchange of India
Financial currency
INR
First seen
2026-05-10
Industry
Health Information Services
Isin
INE115Q01022
Last refreshed
2026-05-10
Market cap
INR 291.1B
Price
INR 1,686
Price currency
INR
Rev Per Employee
4,063,867.2x
Sector
Healthcare
Sic
7370
Symbol
nse/IKS
Website
https://ikshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
2.28%
EV Earnings
44.69x
EV/EBIT
33.01x
EV/EBITDA
28.77x
EV/Sales
9.69x
Forward P/E
34.57x
P/B ratio
12.99x
P/E ratio
43.51x
P/S ratio
9.51x
PEG ratio
1.03x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
29.47%
EBITDA Margin
32.99%
Gross margin
47.52%
Gross Profit
INR 14.5B
Gross Profit Growth
36.89%
Gross Profit Growth Q
49.4%
Net Income
INR 6.6B
Net Income Growth
65.09%
Net Income Growth Q
41.38%
Net Income Growth Quarters
7%
Net Income Growth Years
4%
Pretax Margin
27.19%
Profit Margin
21.68%
Profit Per Employee
INR 880,992
Profitable Years
5
ROIC
25.89
Roic5y
54.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

9
MetricValue
Cagr1y
15.83%
EPS Growth
64.53
EPS Growth Q
41.18
EPS Growth Quarters
7
EPS Growth Years
4
Revenue Growth
19.54x
Revenue Growth Q
24.01x
Revenue Growth Quarters
7x
Revenue Growth Years
4x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

12
MetricValue
Cash
INR 2.3B
Debt
INR 7.7B
Debt EBITDA
INR 0.74
Debt Equity
INR 0.34
Equity
INR 22.4B
Interest Coverage
11.6
Net Cash
INR -5.4B
Net Cash By Market Cap
INR -1.84
Net Debt EBITDA
INR 0.53
Net Debt Equity
INR 0.24
Tangible Book Value
INR 5.3B
Tangible Book Value Per Share
INR 31.48

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.34%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
15.81%
200-day SMA
1,564.8
50-day SMA
1,440.6
50-day SMA vs 200-day SMA
50under200
All Time High
2,189
All Time High Change
-22.98%
All Time High Date
2024-12-26
All Time Low
1,236.8
All Time Low Change
36.32%
All Time Low Date
2025-04-07
ATR
59.95
Beta1y
0.44
Beta2y
0.56
Ch YTD
1.7
High
1,714.6
High52
1,876
High52 Date
2025-06-17
High52ch
-10.13%
Low
1,686
Low52
1,262
Low52 Date
2026-03-23
Low52ch
33.6%
Ma50ch
17.04%
Price vs 200-day SMA
7.74%
RSI
72.73
RSI Monthly
42.05
RSI Weekly
57.75
Sharpe ratio
0.46x
Sortino ratio
0.9
Total Return
-0.34%
Tr YTD
1.7
Tr1m
19.42%
Tr1w
0.43%
Tr3m
0.44%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

4
MetricValue
Operating Income
INR 9B
Operating Income Growth
58.26
Operating Income Growth Q
62.36
Operating margin
29.47

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
41,645,062%
Shares Insiders
57.53%
Shares Institutions
11.54%
Shares Out
171,609,259
Shares Qo Q
0.03%
Shares Yo Y
0.34%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

42
MetricValue
Average Volume
479,053.75x
Bv Per Share
134
Ch1m
19.42
Ch1w
0.43
Ch1y
15.81
Ch3m
0.44
Ch6m
1.55
Change
-0.57%
Change From Open
-0.57
Close
1,695.7
Days Gap
0
Depreciation Amortization
1,076,897,500
Dollar Volume
118,820,850
Earnings Date
2026-05-13
EBIT
INR 9B
EBITDA
INR 10.1B
EPS
INR 38.99
F Score
2
Fiscal Year End
March
Founded
2,006
Graham Number
342.91966
Graham Upside
-79.66
Income Tax
INR 1.7B
Is Primary Listing
1
Last Earnings Date
2026-02-04
Last Report Date
2025-12-31
Ma150
1,564.1
Ma150ch
7.79%
Ma20
1,544.9
Ma20ch
9.13%
Next Earnings Date
2026-05-13
Open
1,695.7
Position In Range
0
Price Date
2026-05-08
Price EBITDA
INR 28.84
Ptbv Ratio
55.32
Relative Volume
0.15x
Revenue
30,600,920,000x
Tax By Revenue
5.51x
Tax Rate
20.27%
Tr6m
1.55%
Volume
70,475
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does NSE/IKS pay a dividend?

Capital-return profile for this ticker.

Performance

NSE/IKS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+15.8%
S&P 500 1Y: n/a
3Y total return
n/a
S&P 500 3Y: n/a
5Y total return
n/a
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns NSE/IKS?

Insider, institutional, and short-interest positioning.

Institutional ownership
+11.5%
Share of float held by funds and institutions
Insider ownership
+57.5%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+0.3%
Negative means the company is buying back shares.
Technical

NSE/IKS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
72.7
Above 70: short-term overbought
Price vs 200-day MA
+7.7%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
0.46
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About NSE/IKS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/IKS stock rating?

nse/IKS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/IKS analysis?

The full report lives at /stocks/nse/IKS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/IKS?

The latest report frames nse/IKS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/IKS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.